Medicus Pharma Ltd. Common Stock (MDCX) vs Tvardi Therapeutics, Inc. (TVRD)

A side-by-side comparison of Medicus Pharma Ltd. Common Stock and Tvardi Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Medicus Pharma Ltd. Common Stock logo
MDCX
Medicus Pharma Ltd. Common Stock
$10M
$0.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Tvardi Therapeutics, Inc. logo
TVRD
Tvardi Therapeutics, Inc.
$10M
$1.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — MDCX vs TVRD

growth of $100 · dividends reinvested · last 1y
MDCX -95.6% (-95.6%/yr)TVRD -76.7% (-76.7%/yr)TVRD compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002026$4$23
MDCX TVRD

MDCX vs TVRD: by the numbers

  • •TVRD is the larger company ($10M vs $10M market cap).

Metrics side by side

Valuation

MetricMDCXTVRD
P/B ratioN/A1.21

Profitability

MetricMDCXTVRD
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROEN/A-310.94%
ROIC-269.16%-323.71%

Go deeper

Full MDCX analysisFull TVRD analysisInteractive comparison tool

Dig into the metrics

Medicus Pharma Ltd. Common Stock ROETvardi Therapeutics ROEMedicus Pharma Ltd. Common Stock operating marginTvardi Therapeutics operating marginMedicus Pharma Ltd. Common Stock revenue growthTvardi Therapeutics revenue growthMedicus Pharma Ltd. Common Stock free cash flowTvardi Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.